Barrington Research Downgrades Haemonetics (HAE) to Market Perform
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $78.78 +1.78%
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Rating Summary:
10 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 5
Join SI Premium – FREE
Barrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $43.80 yesterday.
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $43.80 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Downgrades Gentherm Incorporated (THRM) to Hold
- Prabhudas Lilladher Downgrades Hindustan Petroleum (HPCL:IN) to Reduce (4)
- Jefferies Downgrades Delivery Hero SE (DHER:GR) (DLVHF) to Hold
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
